News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Insulet Corporation to Report First Quarter 2013 Financial Results on May 6, 2013



4/24/2013 10:06:02 AM

BEDFORD, MA--(Marketwired - April 23, 2013) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, announced plans to release its financial results for the first quarter of 2013 on May 6, 2013 after the close of the financial markets.

Insulet will also host a conference call at 5:00 p.m. Eastern Time on May 6, 2013 to discuss its first quarter financial results. During the conference call, material information concerning the Company, its operations, strategies and prospects may be discussed.

To listen to the conference call, please dial (877) 831-5664 for domestic callers and (832) 412-1780 for international callers. The passcode is 53298530. A replay of the conference call will be available two hours after the completion of the call through July 6, 2013 by dialing (855) 859-2056 (domestic) and (404) 537-3406 (international), passcode 53298530. An online archive of the conference call will also be available by accessing the Investor Information section of the company's website at http://investors.insulet.com.

About Insulet Corporation
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and fully-automated cannula insertion. Insulet's subsidiary, Neighborhood Diabetes, is a leading distributor for diabetes products and supplies, delivered through a high touch customer service model. Founded in 2000, Insulet Corporation is based in Bedford, Mass. For more information, please visit: http://www.myomnipod.com.


Contact:
Stephanie Marks for Insulet Corporation
smarks@lazarpartners.com
212-843-0211


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES